Discover
CATX
Perspective Therapeutics, Inc.
1.15
2500 x 1.13
4500 x 1.14
bid
ask
-
0.02
1.71%
3500 @ 05:53 PM
1.14 -0.01 (0.87%)
| Ytd | -58.18% | |
| 1y | -56.44% |
1.09
day range
1.15
1.06
52 week range
6.16
| Open | 1.12 | Prev Close | 1.17 | Low | 1.09 | High | 1.15 | Mkt Cap | 131.27M |
| Vol | 2.31M | Avg Vol | 2.02M | EPS | -1.33 | P/E | N/A | Forward P/E | -2.91 |
| Beta | 1.47 | Short Ratio | 4.69 | Inst. Own | 81.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 2.61 | 200-d Avg | 3.55 | 1yr Est | 16.15 |
| Income Statement | |||
| Total Revenue | 81.00K | ||
| Revenues (USD) | 81.00K | ||
| Gross Profit | 81.00K | ||
| Operating Expenses | 29.34M | ||
| Research and Development Expense | 21.54M | ||
| Selling, General and Administrative Expense | 7.80M | ||
| Operating Income | -29.26M | ||
| Interest Expense | 71.00K | ||
| Net Income | -26.79M | ||
| Net Income Common Stock | -26.79M | ||
| Net Income Common Stock (USD) | -26.79M | ||
| Consolidated Income | -26.79M | ||
| Net Income from Discontinued Operations | -197.00K | ||
| Earnings per Basic Share | -0.22 | ||
| Earnings per Basic Share (USD) | -0.22 | ||
| Earnings per Diluted Share | -0.22 | ||
| Earning Before Interest & Taxes (EBIT) | -26.71M | ||
| Earning Before Interest & Taxes (USD) | -26.71M | ||
| Weighted Average Shares | 120.65M | ||
| Weighted Average Shares Diluted | 120.65M | ||
| Balance Sheet | |||
| Cash and Equivalents | 48.49M | ||
| Cash and Equivalents (USD) | 48.49M | ||
| Investments | 188.39M | ||
| Investments Current | 188.39M | ||
| Trade and Non-Trade Receivables | 269.00K | ||
| Current Assets | 241.52M | ||
| Property, Plant & Equipment Net | 109.99M | ||
| Total Assets | 392.03M | ||
| Debt Current | 1.15M | ||
| Total Debt | 3.96M | ||
| Current Liabilities | 36.54M | ||
| Debt Non-Current | 2.81M | ||
| Total Liabilities | 68.16M | ||
| Accumulated Retained Earnings (Deficit) | -387.81M | ||
| Accumulated Other Comprehensive Income | -221.00K | ||
| Shareholders Equity | 323.86M | ||
| Shareholders Equity (USD) | 323.86M | ||
| Assets Non-Current | 150.50M | ||
| Total Debt (USD) | 3.96M | ||
| Deferred Revenue | 26.60M | ||
| Goodwill and Intangible Assets | 40.00M | ||
| Liabilities Non-Current | 31.62M | ||
| Trade and Non-Trade Payables | 29.42M | ||
| Tax Liabilities | 1.70M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.14M | ||
| Net Cash Flow from Financing | 147.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.48M | ||
| Capital Expenditure | -14.19M | ||
| Issuance (Purchase) of Equity Shares | 160.00K | ||
| Issuance (Repayment) of Debt Securities | -13.00K | ||
| Net Cash Flow from Investing | 15.02M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 29.24M | ||
| Net Cash Flow from Operations | -20.65M | ||
| Share Based Compensation | 3.05M | ||